Pieter A. Doevendans
Papers
2
Total Citations
31
H-Index
2
About
Pieter A. Doevendans is a leading cardiovascular researcher whose work bridges interventional cardiology, biomedical engineering, and non-invasive therapeutics. His primary research focus is the development of novel, minimally invasive treatments for peripheral artery disease (PAD), with a particular emphasis on robot-assisted high-intensity focused ultrasound (HIFU) technology. Doevendans has made pioneering contributions to the preclinical validation of arterial wall targeting using dual-mode ultrasound arrays (DMUA), demonstrating both the safety and feasibility of this approach for noninvasive thermal ablation of atherosclerotic plaques. His landmark 2020 study on the subject, which has garnered 21 citations, established a critical proof-of-concept for translating HIFU from bench to bedside. Building on this foundation, he designed and published the protocol for a first-in-human pilot study (2022, 10 citations) to evaluate robot-assisted HIFU therapy for femoral artery plaques—a potential game-changer for PAD patients who face limited long-term patency with current revascularization methods. Doevendans’ work is notable for its direct clinical translation pathway, combining rigorous safety data with innovative robotic precision, positioning him at the forefront of non-invasive cardiovascular intervention.
Research Focus
Key Achievements
Top Papers
- 1
- 2